Guilleminault
@Guilleminault3
ID:1245265942692737024
01-04-2020 08:25:22
691 Tweets
138 Followers
118 Following
Discover the benefits of #Omalizumab in treating multiple #food #allergies . Learn more at NEJM. #FoodAllergies #Treatment bit.ly/3V0rjNE
Sanofi is moving forward with the development of the CSU medication #rilzabrutinib in a Phase III trial: rilzabrutinib improved itch, hives, and urticaria in a Phase II trial in patients with chronic spontaneous #urticaria . #Sanofi #ClinicalTrials bit.ly/3TePiYt
Real-time acute lung 🫁 rejection diagnosis using Endomicroscopy #pCLE , results from the #CELTICS ☘️ study. Thomas Villeneuve CHU de Toulouse
sciencedirect.com/science/articl…
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England thorax.bmj.com/content/79/3/2… SPH- Respiratory electronic health records
In Current Issue! #Standardized #Quantification of Mast #Cells in the #Gastrointestinal Tract in #Adults buff.ly/3HXwial
La SFAR félicite, le professeur Thomas GEERAERTS, anesthésiste réanimateur, membre actif de la SFAR, nommé doyen directeur du département médecine maïeutique paramédical de Toulouse 👏
SFAR Jeunes AJAR France 🇫🇷 SNPHARE Syndicat National des Jeunes Anesth-Réa SNARF IADE de France Fédération Nationale des Infirmiers de Réanimation
To arms! Public funding for research in Canada ranks among the weakest in the G7 when considered against GDP.
🚀🔬 #ResearchFunding #InnovationMatters #SupportScience
In current issue! Long-term follow-up of #children who achieved sustained #unresponsiveness after #peanut #oral #immunotherapy buff.ly/3OoBk3r